Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Goos

Showing results (211-220 of 215) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 215 results.
Annals of Surgery|January 8, 2015
Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver MetastasisJeroen A C M Goos, Erienne M V de Cuba, Veerle M H Coupé, et al.
Oncotarget|October 27, 2015
A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9Jeroen A C M Goos, Veerle M H Coupé, Mark A van de Wiel, et al.
Oncotarget|July 15, 2015
MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patientsKristiaan Lenos, Jeroen A C M Goos, Ilona M Vuist, et al.
British Journal of Cancer|November 18, 2016
Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrenceSjoerd H den Uil, Veerle M H Coupé, Janneke F Linnekamp, et al.
British Journal of Cancer|September 5, 2013
Maspin is a marker for early recurrence in primary stage III and IV colorectal cancerN Snoeren, B L Emmink, M J G Koerkamp, et al.
Pageof 22

Showing results (211-220 of 215) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 215 results.
Annals of Surgery|January 8, 2015
Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver MetastasisJeroen A C M Goos, Erienne M V de Cuba, Veerle M H Coupé, et al.
Oncotarget|October 27, 2015
A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9Jeroen A C M Goos, Veerle M H Coupé, Mark A van de Wiel, et al.
Oncotarget|July 15, 2015
MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patientsKristiaan Lenos, Jeroen A C M Goos, Ilona M Vuist, et al.
British Journal of Cancer|November 18, 2016
Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrenceSjoerd H den Uil, Veerle M H Coupé, Janneke F Linnekamp, et al.
British Journal of Cancer|September 5, 2013
Maspin is a marker for early recurrence in primary stage III and IV colorectal cancerN Snoeren, B L Emmink, M J G Koerkamp, et al.
Pageof 22